L-Aspartic Acid

We are L-Aspartic Acid CAS:56-84-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


L-Aspartic Acid
 
L-Aspartic acid (L-aspartate) is a nonessential amino acid that plays a key role in the malate-aspartate shuttle in the cell. It is widely used as an ingredient in infusion and infant formula.

Cas.No 56-84-8
Assay 99.0-101.0%
Specification White crystals or crystalline powder, odorless, slightly acid taste
Applications Infusion
Packaging 25kg&50kg
Pharmacopeia JP,USP,EP,FCC
STORAGE Controlled room temperature in tight container

 
SPECIFICATION AND PROCEDURE

State of solution
(Transmittance)
Not Less Than 98.0%
pH 2.5~3.5
Specific rotation[α]20D +24.5~+25.5°
Ammonium (NH4) Not More Than 0.020%
Chloride (Cl) Not More Than 0.020%
Sulfate (SO4) Not More Than 0.020%
Iron (Fe) Not More Than 10 ppm
Heavy metals (Pb) Not More Than 10 ppm
Lead (Pb) ** Not More Than 5 ppm
Arsenic (As2O3) Not More Than 1 ppm
Loss on drying Not More Than 0.20%
Residue on ignition Not More Than 0.10%
Related substances Not More Than 0.4%
Endotoxin* Less Than 6.0 EU/g
Assay (dry basis) 99.0~101.0%

· * The endotoxin-certified grade will be supplied on request.
· ** This test is done for FCC grade.
· This product meets requirements of residual solvents listed in the current JP, USP and EP.
 

L-Aspartic Acid


Related News: We manufacture APIs and drug manufacturers make medicines from APIs.2-acetyl-5-methylfuran CAS:1193-79-9 “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.1-[2-Amino-1-(4-methoxyphenyl)ethyl]cyclohexanol Hydrochloride CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion.(3aR,4S,7R,7aS)-Hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione CAS:14805-29-9 CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion.The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

Related Products
Product Name
4-[(4-hydroxy-6-oxo-1H-pyrimidin-2-yl)amino]benzonitrile View Details
1-Chloro-3-isocyanatobenzene View Details
(Bromomethyl)cyclobutane View Details
N-((4-Chloromethyl)-2-thiozolyl)guanidine hydrochloride manufacturer 5-azacytosine manufacturer Cetrorelix acetate manufacturer 2-Chloro-4-methoxy-5-nitropyridine manufacturer tert-butyl 4-(6-nitropyridin-3-yl)piperazine-1-carboxylate manufacturer